AKT1 and acute lymphoblastic leukemia: Nonetheless, sensitivity to DW0254 positively correlates with response to AKT inhibitors, at least in T-ALL cell lines, suggesting that PDE6D inhibition effectively triggers a downstream anti-leukemic response in AKT dependent cells.